Related Experiment Video
Updated: Sep 22, 2026

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
Published on: March 8, 2018
[Characteristics of diabetic macroangiopathy of the lower extremities]
Abstract:
Macroangiopathy of the lower extremities is one of the most frequent complications of diabetes and has a very adverse impact on the quality of life of the patients. It affects approximately as much as half the diabetics with the duration of the disease for more than 15 years. It is encountered in two forms. The first type of affection--obliterating atherosclerosis--reminds of affections of the arteries of the lower extremities in the non-diabetic population, although some differences in the site of affection, morphology of sclerotic changes as well as the spectrum of risk factors were found, when compared with obliterating atherosclerosis in non-diabetics. Risk factors of this form of macroangiopathy include cholesterol, triacylglycerols, reduced values of HDL-cholesterol, hypertension, fibrinogen, smoking and apparently also albuminuria. The second form of macroangiopathy--mediocalcinosis--is not associated with the mentioned risk factors of atherosclerosis but is probably the consequence of diabetic neuropathy. Contrary to atherosclerosis, it does not lead to the development of obliteration but has also an adverse effect on the function of blood vessels. Its incidence correlates with the duration and compensation of diabetes as well as deteriorated perception of vibrations. With regard to the high incidence of gangrenes requiring amputation, it seems rational to influence in diabetics all known risk factors of macroangiopathy although convincing results of long-term intervention studies are still lacking.
Insights
Diabetic macroangiopathy affects half of long-term diabetics, presenting as atherosclerosis or mediocalcinosis. Managing risk factors is crucial for preventing lower extremity complications like gangrene.
Area of Science:
- Vascular Medicine
- Diabetology
- Public Health
Context:
- Diabetic macroangiopathy significantly impacts lower extremity health and patient quality of life.
- Affects up to 50% of diabetic patients with disease duration exceeding 15 years.
- Characterized by two distinct forms: obliterating atherosclerosis and mediocalcinosis.
Purpose:
- To delineate the characteristics and risk factors of macroangiopathy in diabetic patients.
- To differentiate between atherosclerotic and non-atherosclerotic macroangiopathy in diabetes.
- To highlight the clinical implications for diabetic foot complications.
Summary:
- Obliterating atherosclerosis in diabetics shares similarities with non-diabetics but has unique risk factors including hyperlipidemia, hypertension, and smoking.
- Mediocalcinosis, likely linked to diabetic neuropathy, affects vascular function without causing arterial obliteration.
- Risk factors for atherosclerotic macroangiopathy include high cholesterol, triglycerides, low HDL, hypertension, fibrinogen, smoking, and albuminuria.
Impact:
- Understanding these macroangiopathic forms is vital for preventing severe outcomes like gangrene and amputation in diabetic populations.
- Early identification and management of risk factors are recommended, despite limited long-term intervention data.
- Further research into effective long-term interventions for diabetic macroangiopathy is warranted.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Foot Ulcer
Diabetic Retinopathy
Diabetic Nephropathy
Diabetic Neuropathy

